| |
Article Title |
Author(s) |
Pages |
|
|
|
Editorial Board
|
|
i
|
|
|
|
Table of contents
|
|
ii
|
|
|
|
Indications for intrathecal therapy in cancer patients
An essential component of cancer treatment and management is effective pain control, which is vital to the preservation of functioning, quality of life, and potentially survival time. Unfortunately, n...
|
Jacqueline Lozano,
Oscar A. de Leon-Casasola
|
147-149
|
|
|
|
The epidural trial
The epidural trial is an integral part of the success of an intrathecal pump treatment. As described in this article, it will allow the practitioner to test for the best site for catheter placement, d...
|
Hemadevi Chenthilmurugan,
Marchyarn Mahathanaruk,
Oscar A. de Leon-Casasola
|
150-154
|
|
|
|
Implementing and managing intrathecal pumps
The use of intrathecal therapy is associated with increase quality of analgesia and a decrease in side effects in patients who have not tolerated oral pharmacological therapy AND have had a successful...
|
Oscar A. de Leon-Casasola
|
155-157
|
|
|
|
Intrathecal pump implantation techniques
Perioperative complications associated with the implantation of intrathecal pumps can be significantly decreased through the use of a preoperative, intraoperative and postoperative protocols. This art...
|
Julie A. Sparlin,
Oscar A. de Leon-Casasola
|
158-161
|
|
|
|
Complications of intrathecal drug delivery systems
Cancer and its treatments often result in complex combinations of nociceptive and neuropathic pain. Comprehensive pharmacologic management with opioids and antineuropathic medications can result in ad...
|
James M. Hitt,
Oscar A. de Leon-Casasola
|
162-166
|
|
|
|
A critique of the latest consensus panel for intrathecal therapy
Because of the relative lack of placebo and dose-ranging studies regarding the initiation and titration of intrathecal (IT) therapy, the Polyanalgesic Consensus Conference (2007) yielded recommendatio...
|
Matthew Peer,
Oscar A. de Leon-Casasola
|
167-171
|
|
